Toutes les catégories
| Product Name | Description | Action |
|---|---|---|
| Dulaglutide, Trulicity, GLP-1, LY2189265, Agoniste des récepteurs du GLP-1, Protéine de fusion Fc / Protéine de fusion recombinante, N ° CAS 923950-08-7 | Trade Name : Trulicity Target : GLP-1 Molecular Type : Fusion Protein Sales in 2025 (Millions of USD) : 2190(First half of the year) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Atezolizumab | Trade Name : Tecentriq Target : PD-L1 Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 2620(First three quarters) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us... |
|
| Daratumumab, Darzalex, HuMax-CD38, anticorps monoclonaux anti-CD38, anticorps monoclonaux hématologique-oncologique biologique, numéro CAS 945721-28-8 | Trade Name : Darzalex Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 1045(First three quarters) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Secukinumab, Cosentyx, inhibiteur des interleukines, injection sous-cutanée, immunologie biologique, anticorps monoclonaux, n° CAS 875356-43-7 | Trade Name : Cosentyx Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 3163(First half of the year) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Omalizumab, Xolair, Hu-901, Anticorps IgE biologique, Anticorps monoclonal IgG1 humanisé, Anticorps monoclonal immunologique, CAS n° 242138-07-4 | Trade Name : Xolair Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 4100(2024/7/1~2025/7/1) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Ustekinumab, Stelara, Interleukine-12 Interleukine-23, CNTO 1275, Inhibiteur d'interleukine, Agent biologique d'immunologie, Anticorps monoclonal entièrement humain, N° CAS 815610-63-0 | Trade Name : Stelara Target : Interleukin-12 Interleukin-23 Molecular Type : Fully Human Monoclonal Antibody Sales in 2025 (Millions of USD) : 5400(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, ... |
|
| Rituximab | Trade Name : Rituxan Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 520 All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Adalimumab, Humira, TNF-α, D2E7, LU 200134, Agent biologique anti-TNF / inhibiteur de TNF, Anticorps monoclonal entièrement humain, Agent thérapeutique auto-immun / Agent biologique de rhumatologie, N° CAS. 331731-18-1 | Trade Name : Humira Target : TNF-α Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 1410 All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
